Pharmacists can play a critical role in patient education, therapy recommendations, and therapy management in palliative care and should be familiar with appropriate pharmacologic interventions for symptom management.
The NCCN 2019 Nursing Program is designed to provide oncology nurses with current and relevant information related to the management of patients with cancer, including the effects cancer-related therapy can have on morbidity and mortality, and the quality of life of patients with cancer.
The transition to end of life care is a particularly challenging time for oncology clinicians in their interactions with patients, families, and caregivers.
The NCCN Guidelines provide recommendations for managing irAEs as well as guiding principles for immunosuppression in the setting of toxicity. Importantly, these guidelines also provide guidance for multidisciplinary teams regarding clinician and patient education.
Central venous catheters (CVCs) are an important component of cancer treatment and require multidisciplinary care due to significant complications associated with vascular access devices.
As part of a multidisciplinary team, oncology nurses and advanced-practice providers (APPs) are essential for effective disease management and need access to current evidence to incorporate into or inform best practices.
The development of new and innovative cancer treatments has expanded the options available to manage patients with cancer. However, with these advances come challenges for healthcare providers and patients.
Although there is general agreement on the importance and benefits of early integration of palliative care in oncology, timely and seamless integration remains a major challenge.
Although there is general agreement on the importance and benefits of early integration of palliative care in oncology, timely and seamless integration remains a major challenge.
Facebook
Twitter
LinkedIn
Forward